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JMJD2 lysine demethylases (KDMs) participate in
diverse genomic processes. Most JMJD2 homologs
display dual selectivity toward H3K9me3 and
H3K36me3, with the exception of JMJD2D, which is
specific for H3K9me3. Here, we report the crystal
structures of the JMJD2D,2-oxoglutarate,H3K9me3
ternary complex and JMJD2D apoenzyme. Utilizing
structural alignments with JMJD2A, molecular dock-
ing, and kinetic analysis with an array of histone
peptide substrates, we elucidate the specific signa-
tures that permit efficient recognition of H3K9me3
by JMJD2A and JMJD2D, and the residues in
JMJD2D that occlude H3K36me3 demethylation.
Surprisingly, these results reveal that JMJD2A and
JMJD2D exhibit subtle yet important differences in
H3K9me3 recognition, despite the overall similarity
in the substrate-binding conformation. Further, we
show that H3T11 phosphorylation abrogates deme-
thylation by JMJD2 KDMs. Together, these studies
reveal the molecular basis for JMJD2 site specificity
and provide a framework for structure-based design
of selective inhibitors of JMJD2 KDMs implicated in
disease.
INTRODUCTION
Protein lysine methylation is a dynamic posttranslational modifi-
cation that is regulated through the concerted activities of lysine
methyltransferases and lysine demethylases (KDMs). Presently,
there are two known families of KDMs: the flavin-dependent
LSD1 family, and the larger and more diverse Jumonji C (JmjC)
family (Cloos et al., 2008; Mosammaparast and Shi, 2010). The
JmjC KDMs are Fe(II)-dependent hydroxylases that catalyze
lysine demethylation using the cosubstrates 2-oxoglutarate
(2-OG) and molecular oxygen. To date, several subfamilies of
JmjC KDMs have been identified and characterized, including
JHDM1 (KDM2), JHDM2 (KDM3), JMJD2 (KDM4), JARID1,
(KDM5), UTX/JMJD3 (KDM6), and PHF8/KIAA1718 (KDM7).
These KDMs display distinct methylation site and state specific-
ities for lysine residues in histones and in certain nonhistone98 Structure 21, 98–108, January 8, 2013 ª2013 Elsevier Ltd All rightproteins (Allis et al., 2007; Cloos et al., 2008; Krishnan et al.,
2011; Mosammaparast and Shi, 2010; Nottke et al., 2009;
Shi, 2007; Shi and Whetstine, 2007; Upadhyay et al., 2011).
Members of these families have been implicated in regulating
diverse genomic processes, such as transcriptional activation,
gene silencing, cell-cycle progression, heterochromatin mainte-
nance, X chromosome inactivation, and development (Cloos
et al., 2008; Mosammaparast and Shi, 2010; Nottke et al.,
2009; Shi, 2007). The functional roles of the JmjC KDMs vary
according to subfamily and are believed to be a consequence
of their different histone methyllysine substrate specificities.
The JMJD2 family of KDMs is conserved from budding yeast
through mammals (Cloos et al., 2006; Fodor et al., 2006; Katoh
and Katoh, 2004; Kim and Buratowski, 2007; Klose et al., 2006,
2007; Tu et al., 2007; Whetstine et al., 2006). Humans possess
four JMJD2 homologs denoted JMJD2A, JMJD2B, JMJD2C,
and JMJD2D. These enzymes have been implicated in transcrip-
tional regulation, cell-cycle progression, nuclear hormone signal-
ing, embryonic stem cell self-renewal, and development (Black
et al., 2010; Iwamori et al., 2011; Lin et al., 2008; Loh et al.,
2007; Lorbeck et al., 2010; Mosammaparast and Shi, 2010;
Nottke et al., 2009; Shi, 2007; Strobl-Mazzulla et al., 2010). In
addition, overexpression of several JMJD2 homologs has been
linked to cancer. For example, JMJD2B has been implicated in
breast, gastric, and colon cancers (Fodor et al., 2006; Fu et al.,
2012; Kawazu et al., 2011; Li et al., 2011b; Shi et al., 2011; Toyo-
kawa et al., 2011; Yang et al., 2010), whereas JMJD2A, JMJD2C,
andJMJD2Dhavebeen reported tobeoverexpressed inprostate
cancer, in which they function as androgen receptor (AR)
coactivators to upregulate AR target genes (Shin and Janknecht,
2007; Wissmann et al., 2007). More recently, JMJD2D has been
shown to function as a pro-proliferative protein and promote
HCT116 colon cancer cell proliferation (Kim et al., 2012). In addi-
tion to cancer, upregulation of JMJD2A results in epigenetic
changes in cardiac gene expression, promoting hypertrophic
cardiomyopathy (Zhang et al., 2011).
Despite the high sequence identity within their catalytic
domains (>75%), there is a surprising degree of variability in the
substrate specificities among JMJD2 homologs. Most JMJD2
enzymes display dual selectivity in demethylating H3K9me3,
a mark associated with heterochromatin and gene silencing,
and H3K36me3, a modification demarcating the coding regions
of genes that are actively transcribed by RNA polymerase II
(Mosammaparast and Shi, 2010; Whetstine et al., 2006). In con-
trast, JMJD2D efficiently demethylates di- and trimethyl H3K9s reserved
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Structural and Functional Analysis of JMJD2D(H3K9me2/3), but is unable to recognize H3K36me3 (Whetstine
et al., 2006). However, the molecular basis by which JMJD2D
discriminates betweenH3K9me3 andH3K36me3 remains poorly
understood.
To gain insight intomolecular determinants that distinguish the
substrate specificities of different JMJD2 KDMs, we determined
the crystal structure of a JMJD2D,2-OG,H3K9me3 ternary
complex and the JMJD2D apoenzyme. Comparison of the struc-
ture of the JMJD2D ternary complex to JMJD2A,H3K9me3 and
JMJD2A,H3K36me3 peptide complexes reveals structural vari-
ations between their substrate binding clefts that explain their
differentmethylation site specificities. Molecular docking studies
and kinetic analysis of JMJD2A and JMJD2D using a library of tri-
methylated histone H3 peptides corroborates these observa-
tions. Further, our studies demonstrate that recognition of
H3T11 is important for H3K9me3 demethylation by JMJD2
KDMs, as mutations or phosphorylation of this residue disrupt
activity. Collectively, our results define the molecular basis by
whichmethylation site specificity is achieved in the JMJD2 family
and provide a platform for designing substrate-mimetic inhibi-
tors that exploit these structural variations to selectively target
specific JMJD2 homologs.
RESULTS
Structure of the JMJD2D,2-OG,H3K9me3 Ternary
Complex
To elucidate the molecular basis for its discrimination between
the H3K9me3 and H3K36me3 sites, we determined the crystal
structure of the catalytic domain of JMJD2D (residues 12–342)
bound to 2-OG and an H3K9me3 peptide (residues 1–15) at
1.8 A˚ resolution (Figure 1A; Table 1). Simulated annealing omit
maps illustrate clear electron density for residues 6–15 in the
H3K9me3 peptide substrate, the cosubstrate 2-OG, and Ni(II)
that is bound in the Fe(II) coordination site within the active site
(Figure 1B). We also determined a 2.5 A˚ crystal structure of the
JMJD2D apoenzyme (Figure S1A available online; Table 1) con-
taining Ni(II) in the active site. Alignment of the two structures
reveals a high degree of similarity with no major structural varia-
tions induced by substrate binding (RMSDCa = 0.26 A˚ for all
aligned Ca atoms). The JmjC domain (residues 146–312) of
JMJD2D adopts a b-barrel fold that is highly homologous to the
structures of other JMJD2 KDMs (Chen et al., 2006; Hillringhaus
et al., 2011) (Figure 1A). The JmjC domain and C-terminal region
of the enzyme (312–342) harbor a Zn-binding motif (Figure 1A)
composed of residues His-244, Cys-238, Cys-310, and Cys-
312, a structural feature conserved throughout the JMJD2 family
(Chen et al., 2006; Hillringhaus et al., 2011). The overall structure
anddomainsof JMJD2Dare very similar to thoseof JMJD2A,with
an RMSDCa (261 atoms) of 0.4 A˚ (Figure 1C). Prior to the solution
of these structures, two unpublished structures of the JMJD2D
catalytic domain were deposited in the Protein Data Bank (PDB
entries 3DXT and 3DXU) and have been cited in previous studies
(Hillringhaus et al., 2011). In these structures, the C-terminal
region adopts an alternative conformation that is neither
observed in JMJD2A and JMJD2C, nor the JMJD2D structures
reported here (Figures S1A and S1B). This alternative conforma-
tion is presumably stabilized by crystal-packing forces, as a
structural alignment with the JMJD2D ternary complex illustratesStructure 21,that this alternate conformation results in steric clashes between
the N-terminal residues of the H3K9me3 peptide and the enzyme
(Figures S1C and S1D). In addition, Gly-174, which forms part of
the trimethyllysine binding pocket (Figures S1B and S2A), is
shifted 12 A˚ out of the active site in the previously deposited
JMJD2D structures, thus rendering this alternate conformation
incompatible for trimethyllysine recognition and demethylation.
In the active site of JMJD2D, Ni(II) occupies the Fe(II) binding
site and is coordinated by His-192, Gly-194, and His-280 (Fig-
ure S2A). The methyl groups of K9me3 in the H3 peptide are
coordinated by a network of CH,,,O hydrogen bonds to resi-
dues Tyr-181, Glu-194, and Gly-174 in JMJD2D. This binding
mode is conserved in JMJD2A, with the exception that Ala-292
in JMJD2D is substituted by Ser-288 in JMJD2A (Figure S2B;
Couture et al., 2007). The H3K9me3 peptide adopts aW-shaped
conformation with two sharp bends when bound in the histone-
binding cleft of JMJD2D, analogous to the H3K9me3 binding
mode observed in JMJD2A (Couture et al., 2007; Ng et al.,
2007). The first bend occurs at K9me3 and deposits the trime-
thyllysine substrate into a narrow channel leading to the active
site, whereas the second bend corresponds to T11 and positions
the threonyl side chain into a shallow pocket adjacent to the
active site (Figure 1A). A combination of main-chain and side-
chain hydrogen bonds and van der Waals contacts between
the H3K9me3 peptide and JMJD2D facilitate optimal recognition
of the substrate (Figure 1D). Many of these interactions are
conserved in the JMJD2A,H3K9me3 peptide complex, but
upon close inspection, several subtle, albeit significant, differ-
ences were observed in the H3K9me3 binding modes.
H3K9me3 Binding Mode
The H3K9me3 binding mode appears to be conserved between
JMJD2A and JMJD2D, consistent with the similar catalytic effi-
ciencies (kcat/Km values) they display toward an H3K9me3
peptide substrate (Krishnan et al., 2012; Table 2). Recognition
of the H3K9me3 site by JMJD2A and JMJD2D involves hydrogen
bonding or van der Waals contacts with residues R8, S10, T11,
and G12 at the 1, +1, +2, and +3 positions in the H3K9
sequence (Figures 1D and 2). We first examined the interactions
involving R8 recognition that had not been previously character-
ized in JMJD2 enzymes (Couture et al., 2007; Hillringhaus et al.,
2011; Ng et al., 2007). R8 corresponds to the 1 position in the
peptide sequence relative to K9 and is recognized by an intricate
network of hydrogen bonds to Asp-139 and Tyr-179 in JMJD2D
and to Glu-169 in JMJD2A (Figures 2A and 2B). In the case of
both enzymes, an R8A substitution in the H3K9me3 peptide
resulted in 6- to 10-fold decreases in the catalytic efficiencies
(kcat/Km values) compared to demethylation of the wild-type
(WT) peptide (Table 2; Figures 2A and 2B). These decreases
were predominantly due to an increase in the Km values for the
H3K9me3_R8A peptide that is suggestive of impaired binding
to JMJD2A and JMJD2D, highlighting the importance of the
interactions at the 1 position in the overall recognition of the
H3K9me3 site. The residues that interact with R8 are conserved
among all JMJD2 homologs (Figure S3), implying that recogni-
tion of R8 in the 1 position of the H3K9 sequence is conserved
among these enzymes.
With respect to residues in the C-terminal half of the H3K9me3
peptide, S10, T11, and G12, corresponding to the +1, +2, and +398–108, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 99
Figure 1. Crystal Structure of JMJD2D
(A) Structure of the JMJD2D,2-OG,H3K9me3 ternary complex. The JmjN domain (orange), JmjC domain (pink), mixedmotif (blue), and C-terminal motif (red) are
depicted in cartoon representation with the secondary structural elements labeled. The cyan sphere represents Ni(II) in the active site; the gray sphere represents
Zn(II) in the Zn-binding motif. Stick representation of the cofactor 2-OG (black carbon atoms) and the substrate H3K9me3 peptide (green carbons) are shown.
(B) Simulated annealing Fo-Fc omit maps are contoured at 3.0 s for 2-OG and Ni(II) (inset) and 2.0 s for the H3K9me3 peptide. *Two conformations were observed
for S10 and each was modeled with an occupancy of 0.5. zThe side chain of K14 was not modeled due to a lack of clear electron density.
(C) Alignment of JMJD2A (PDB entry 2OS2) (blue) and JMJD2D (pink) (RMSD Ca = 0.4 A˚).
(D) Interactions between the H3K9me3 peptide substrate (green carbons) and JMJD2D (pink). Intrapeptide and enzyme-peptide hydrogen bonds are depicted as
orange- and black-dashed lines, respectively.
See also Figures S1 and S2.
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Structural and Functional Analysis of JMJD2Dpositions, adopt a bent conformation that enables these amino
acids to bind efficiently inside a pocket adjacent to the active
site, as observed in the structures of JMJD2A,H3K9me3 peptide
complexes (Figures 2C and 2D) (Couture et al., 2007; Ng et al.,
2007). In JMJD2D, the bent conformation is maintained through
two hydrogen-bond networks: (1) S10 adopts two alternate side-
chain conformations that enable intrapeptide hydrogen bonding
to either the G12 carbonyl oxygen and amide nitrogen or to the
R8 carbonyl oxygen; and (2) a hydrogen bond between the
side chains of T11 and Asp-139 in JMJD2D (Figure 2C). Mutation
of S10 to alanine (S10A) or T11 to alanine (T11A) resulted in only
a 2-fold reduction in the catalytic efficiency compared to the WT
peptide with JMJD2D (Table 2; Figure 2C). A double S10A_T11A
mutation, however, yielded a 6-fold decrease in catalytic effi-
ciency, indicating that a combination of interactions to S10 and100 Structure 21, 98–108, January 8, 2013 ª2013 Elsevier Ltd All righT11 is important for optimal recognition of the H3K9me3 site
by JMJD2D. The mode of recognition of S10 and T11 by
JMJD2D starkly contrasts the interactions of these residues
with JMJD2A. In a JMJD2A,H3K9me3 complex, the bent
conformation of the C-terminal region of the peptide is stabilized
only by intrapeptide hydrogen bonds between the side-chain
hydroxyl group of S10 and the backbone oxygen and nitrogen
atoms of G12 (Figure 2D). In addition, T11 is rotated away from
Asp-135 and does not form hydrogen bonds with JMJD2A,
unlike the orientation in JMJD2D (Figures 2C and 2D). An S10A
mutation abrogated H3K9me3 recognition by JMJD2A with an
12-fold decrease in catalytic efficiency and an 8-fold increase
in the Km value compared to the wild-type H3K9me3 peptide
(Table 2; Figure 2D). Conversely, a T11A mutation did not affect
recognition of the H3K9me3 site, consistent with the lack ofts reserved
Table 1. Crystallographic Data and Refinement Statistics
JMJD2D,2-
OG,H3K9me3
JMJD2D
Apoenzyme
RCSB PDB ID 4HON 4HOO
Data Collection
Beamline APS 21-ID-G APS 21-ID-G
Wavelength (A˚) 0.9786 0.9786
Space Group P212121 P32
Cell Dimensions
a,b,c (A˚)
72.2, 79.7, 176.0 73.1, 73.1, 136.0
Resolution Range (A˚)a 25.0–1.80
(1.84–1.80)
25.0–2.50
(2.57–2.50)
Rmerge (%)
a 6.00 (41.80) 5.90 (43.20)
I/sI a 31.27 (5.25) 18.60 (2.40)
Completeness (%)a 94.50 (100.0) 91.50 (87.0)
Unique Reflections 89,438 25,850
Redundancya 13.70 (10.60) 5.30 (3.10)
Refinement and Validationb
No. of Reflections 84,616 24,508
No. of Atoms 5891 5347
Protein Atoms 5347 5182
Ligand Atoms 133 4
Solvent Atoms 411 161
Rwork/Rfree
c 18.9/21.4 20.7/24.6
B-Factors (A˚2)
Overall 20.5 39.0
Protein 19.7 39.5
Ligands 33.5 46.9
Waters 26.3 21.0
Root Mean Square Deviation
Bond Length (A˚) 0.016 0.013
Bond Angles () 1.43 1.49
MolProbity Scores
Clashscore (all atoms)d 6.85 (90th
percentile n = 837)
7.94 (98th
percentile n = 271)
Molprobity Score 1.41 (96th
percentile n = 11,444)
2.23 (89th
percentile n = 6960)
Resolution Range (A˚) 1.80 ± 0.25 2.50 ± 0.25
Ramachandran
Favored (%) 98.5 95.7
Allowed (%) 1.5 4.3
Outliers (%) 0 0
aValues in parentheses correspond to the highest-resolution shell.
bStructures were refined in Refmac (Murshudov et al., 1997) using
isotropic temperature-factor refinement.
cRwork = S jjFojjFcjj/S jFoj ; Rfree = 5% of the total reflections.
dClashscore is the number of serious steric overlaps (>0.4 A˚) per 1,000
atoms.
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Structural and Functional Analysis of JMJD2Dhydrogen bonding between T11 and JMJD2A (Figure 2D;
Table 2). Interestingly, a T11S mutation resulted in a 6- to 10-
fold increase in the kcat/Km values for JMJD2A and JMJD2D
compared to the WT H3K9me3 peptide (Table 2; Figure S4),
primarily due to a decrease in the Km values for both enzymesStructure 21, 9(Table 2). The presence of a serine residue at the +2 position cor-
responding to H3T11 may be more amenable to hydrogen
bonding to the carboxylate group of Asp-139 in JMJD2D (Asp-
135 in JMJD2A) compared to the bulkier threonyl side chain,
which has more limited conformational freedom due to steric
constraints within the enzyme’s +2 binding pocket. In summary,
the structural and kinetic data illustrate that R8 is recognized in
a highly conserved manner in both JMD2A and JMJD2D, and
they highlight major variations in the recognition of S10 and
T11 by these enzymes, despite the homology of the H3K9me3
peptide conformation and the structural conservation of the +1
and +2 binding pockets in these homologs.
Previous studies have demonstrated that other posttransla-
tional modifications in the residues flanking H3K9me3 can influ-
ence K9me3 demethylation by JMJD2 KDMs. For example,
phosphorylation of S10 (S10ph) has been shown to abolish
H3K9me3 demethylation by JMJD2A (Ng et al., 2007), consistent
with the importance of this residue in H3K9me3 recognition.
In contrast, the presence of H3T11ph has been reported to
enhance demethylation of H3K9me3 by JMJD2C and promote
the upregulation of AR target genes (Metzger et al., 2008).
Contrary to this finding, we observed that JMJD2A, JMJD2B,
JMJD2C, and JMJD2D are essentially inactive toward an
H3K9me3T11ph peptide, indicating that T11ph abrogates
H3K9me3 demethylation by JMJD2 KDMs (Figure S5A). These
data are corroborated by the structures of JMJD2A and JMJD2D
in complex with H3K9me3 peptides, illustrating that the dimen-
sions of the +2 binding pocket that recognizes H3T11 sterically
preclude the binding of T11ph in the H3K9me3 site (Figure S5B).
H3K36me3 Recognition and Discrimination
Despite their high sequence identity (>75%) and structural
homology, members of the JMJD2 family exhibit striking differ-
ences in their substrate specificities with respect to H3K36me3.
JMJD2A, JMJD2B, and JMJD2C exhibit dual selectivity toward
H3K9me3 and H3K36me3, whereas JMJD2D specifically deme-
thylates H3K9me3 and is essentially inactive toward H3K36me3
(Table S1; Whetstine et al., 2006). To understand the molecular
determinants underlying this varied specificity,we superimposed
the structure of a JMJD2A,NOG,H3K36me3 complex (Chen
et al., 2007) on the structure of our JMJD2D ternary complex.
Based on this alignment, we identified several regions flanking
the substrate binding cleft that differ in either sequence or
structural conservation between the enzymes (Figure 3A). To
ascertain whether these differences account for the preferen-
tial recognition by JMJD2D of H3K9me3 versus H3K36me3,
we docked the H3K36me3 peptide into the substrate bind-
ing cleft of JMJD2D based on the superimposition of the
JMJD2A,H3K36me3 and JMJD2D,H3K9me3 complexes (Fig-
ure 3A). The docking revealed minor steric clashes between
JMJD2D and histone H3 residues N-terminal to K36 in the
H3K36me3 peptide, whereas more severe steric clashes and
electrostatic repulsion were observed with the histone H3 resi-
dues C-terminal to K36me3. Notably, there were pronounced
clashes between H39 and R40 in the H3K36me3 peptide and
His-90 and Leu-75 in JMJD2D (Figure 3B). The corresponding
residues in JMJD2A, Asn-86 and Ile-71, adopt conformations
that accommodate H39 and R40 through van der Waals interac-
tions (Figure 3C). Further, Asp-135 in JMJD2A forms a salt bridge8–108, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 101
Table 2. JMJD2D and JMJD2A Kinetic Data
JMJD2D JMJD2A
Km (mM) kcat (min
1) kcat/Km 3 10
3 (min1 mM1) Km (mM) kcat (min
1) kcat/Km 3 10
3 (min1 mM1)
H3K9me3 53 ± 9 2.3 ± 0.2 45 ± 4 56 ± 9 1.7 ± 0.1 31 ± 4
H3K9me3_R8A 240 ± 27 1.6 ± 0.1 6.9 ± 0.9 340 ± 110 0.94 ± 0.19 2.9 ± 0.5
H3K9me3_S10A 96 ± 15 1.6 ± 0.2 17 ± 3 420 ± 19 1.0 ± 0.1 2.5 ± 0.1
H3K9me3_T11A 100 ± 13 2.5 ± 0.2 25 ± 2 40 ± 8 1.6 ± 0.1 43 ± 10
H3K9me3_S10A_T11A 110 ± 31 0.73 ± 0.13 6.8 ± 0.8 430 ± 32 1.1 ± 0.1 2.6 ± 0.1
H3K9me3_T11S 16 ± 1 3.6 ± 0.1 230 ± 22 9.4 ± 1.4 2.9 ± 0.2 320 ± 37
H3K36me3 NA NA NA 130 ± 6 1.2 ± 0.2 9.3 ± 1.4
H3K36me3_R40A NA NA NA 830 ± 81 2.2 ± 0.2 2.7 ± 0.2
H3K9K36me3 NA NA NA 920 ± 150 0.57 ± 0.03 0.63 ± 0.07
H3K36K9me3 1400 ± 200 1.0 ± 0.1 0.75 ± 0.08 320 ± 28 0.82 ± 0.01 2.6 ± 0.3
H3K36K9me3_V35R 280 ± 12 2.2 ± 0.2 7.9 ± 0.3 19 ± 8.8 1.0 ± 0.1 62 ± 19
Kinetic characterization of JMJD2D and JMJD2A. The amino acid sequences of the peptides used in the assay are listed in Table S2. NA, no activity
detected. See also Tables S1 and S2.
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Structural and Functional Analysis of JMJD2Dwith R40, an interaction that is pivotal for recognition of
H3K36me3, as illustrated by the impaired demethylation of an
H3K36me3_R40A peptide (Table 2; Figure 3C). Corroborating
these observations, mutation of Ile-71 to a leucine (I71L) resulted
in a 16-fold decrease in catalytic efficiency of JMJD2A toward
H3K36me3 but no discernible effect on H3K9me3 demethylation
(FigureS6). Additionally, theC terminusof theH3K36me3peptide
harbors a positively charged cluster of residues comprising H39,
R40, and R42 that is juxtaposed to a positively charged patch on
the surface of JMJD2D that includes Lys-91 and Lys-92, which
may further preclude H3K36me3 binding via electrostatic repul-
sion (Figure 3D). In JMJD2A, Lys-91 and Lys-92 correspond to
neutral amino acids Ile-87 and Gln-88 (Figure 3E).
In addition to accommodating the H3K36me3 substrate with-
out steric or electrostatic clashes, JMJD2A engages in several
productive interactions along the length of the H3K36me3 pep-
tide that promote substrate recognition (Chen et al., 2007). At
the 1 position of the H3K36me3 site, the amide nitrogen of
V35 engages in a hydrogen bond with the backbone carbonyl
oxygen of Asp-311 in the loop linking helices a9 and a10 in the
C-terminal region of JMJD2A (Figure 3F). This interaction facili-
tates the proper positioning of K36me3 substrate in the active
site (Chen et al., 2007; Couture et al., 2007; Ng et al., 2007).
Both the sequence and conformation of the loop that interacts
with V35 vary substantially between JMJD2A and JMJD2D. In
JMJD2A, residues Arg-309, Lys-310, Asp-311, and Met-312
form a broad U-shaped loop that bends sharply near the
peptide-binding cleft, positioning the carbonyl oxygen of Asp-
311 for hydrogen bonding to the V35 amide (Figure 3F). In
JMJD2D, this loop, consisting of residues Gly-313, Glu-314,
Ala-315, and Arg-316 (denoted as the GEAR motif), is oriented
away from thepeptide-binding cleft and does not adopt a confor-
mation that is conducive to hydrogen bonding to V35 in histone
H3. Collectively, the structural comparisons between JMJD2A
and JMJD2D combined with the JMJD2D,H3K36me3 docking
analysis suggests that the loss of productive enzyme-substrate
interactions coupled with multiple steric clashes and electro-
static repulsion precludes the recognition of the H3K36me3
site by JMJD2D.102 Structure 21, 98–108, January 8, 2013 ª2013 Elsevier Ltd All righBiochemical analysis of JMJD2D mutants based on sequence
comparison with JMJD2A revealed that individual point muta-
tions in the substrate-binding cleft were insufficient to enhance
the activity of JMJD2D toward H3K36me3, and clustered muta-
tions in JMJD2D significantly diminished enzyme stability (data
not shown). Thus, to substantiate our structural observations,
we assayed the catalytic activity of JMJD2D with hybrid peptide
substrates bearing the N-terminal and C-terminal halves of the
H3K9 and H3K36 methylation sites (Figure 4A). When assayed
with a peptide composed of the N-terminal half of the H3K9
site and the C-terminal half of the H3K36 site (H3K9K36me3),
JMJD2D exhibited no appreciable activity, consistent with its
inability to demethylate the H3K36me3 peptide (Figure 4B). In
contrast, JMJD2D displayed a substantial increase in its cata-
lytic efficiency toward an H3K36K9me3 peptide composed of
the N- and C-termini of H3K36 and H3K9 sites, respectively,
although this activity was relatively weak compared to that
observed for H3K9me3 (Table 2). These results corroborated
observations from our docking studies, indicating that the resi-
dues C-terminal to K36 in histone H3 are primarily responsible
for the discrimination of JMJD2D against this site. As noted
earlier, the loop containing the GEAR motif in JMJD2D does
not adopt a conformation that is conducive to hydrogen bonding
with V35 in histone H3 (Figure 3F). To introduce a productive
interaction at the 1 position of the demethylation site, V35
was mutated to an arginine (V35R) to mimic the interactions of
R8 in the H3K9me3 peptide with JMJD2A and JMJD2D (Figures
2A and 2B). When assayed with the H3K36K9me3_V35R
peptide, JMJD2D displayed a 10-fold increase in the kcat/Km
compared to the H3K36K9me3 hybrid substrate (Figure 4B;
Table 2).
To complement these results, we next analyzed the kinetic
parameters of JMJD2A using the H3 hybrid peptides. Consistent
with JMJD2D, JMJD2A displayed weak activity toward the
H3K9K36me3 peptide, suggesting that the residues preceding
K36 in histone H3 contribute to substrate recognition (Table 2).
Unexpectedly, when JMJD2A was assayed with H3K36K9me3
hybrid peptide, we observed a 4-fold reduction in the kcat/Km
compared to WT H3K36me3 (Table 2). The decrease in catalyticts reserved
Figure 2. Recognition of H3K9me3 by JMJD2 KDMs
Interactions at the 1, +1, and +2 positions observed in the JMJD2D (pink carbons),H3K9me3 (green carbons) complex (A and C) and in the JMJD2A (blue
carbons),H3K9me3 (yellow carbons) complex (B and D). Enzyme-peptide hydrogen bonds and intrapeptide hydrogen bonds are shown as black- and orange-
dashed lines, respectively.
(A and B) Recognition of R8 in the H3K9me3 substrate by JMJD2D (A) and JMJD2A (PDB entry 2OQ6) (B). The catalytic efficiencies (kcat/Km values) of the WT
H3K9me3 and H3K9me3_R8A peptide substrates are illustrated as bar graphs in the insets.
(C and D) Recognition of S10 and T11 in the H3K9me3 substrate by JMJD2D (C) and JMJD2A (D). The kcat/Km values for WT H3K9me3, H3K9me3_S10A,
H3K9me3_T11A, and H3K9me3_S10A_T11A peptide substrates are represented in the insets.
Error bars represent standard error calculated from three replicate assays. See also Figures S3–S5 and S7.
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Structural and Functional Analysis of JMJD2Defficiency for the H3K36K9me3 peptide may have been a conse-
quence of the loss of the salt bridge interaction between R40 in
histone H3 and Asp-135 in JMJD2A (Figure 3C), as an R40A
mutation in the H3K36me3 peptide impairs the catalytic
efficiency of JMJD2A by 4-fold (Table 2). Conversely, JMJD2A
exhibited a 7-fold increase in its catalytic efficiency when as-
sayed with the H3K36K9me3_V35R peptide compared to WT
H3K36me3 (Table 2). This increase in activity presumably reflects
a compensatory effect in which the V35R mutation enhances
interactions with JMJD2A through hydrogen bonding in the 1
position, as observed for R8 in the H3K9me3 site (Figure 2B).
This interaction would offset the mutation of R40 to glycine in
the H3K36K9me3 hybrid substrate (Figure 4A) that abolishes
a salt bridge interaction with Asp-135 in JMJD2A (Figure 3C). In
summary, the kinetic data corroborate our structural alignment
and docking analysis of JMJD2A and JMJD2D, underscoring
that steric clashes and electrostatic repulsion combined with the
loss of productive enzyme-substrate interactions contribute to
the discrimination against H3K36me3demethylation by JMJD2D.
DISCUSSION
The functional diversity within the JMJD2 family has been attrib-
uted to their differential substrate specificities. (Cloos et al., 2008;Structure 21, 9Mosammaparast and Shi, 2010; Nottke et al., 2009; Shi, 2007;
Shi and Whetstine, 2007). JMJD2A, JMJD2B, and JMJD2C
can efficiently demethylate H3K9me3 and H3K36me3, whereas
JMJD2D is specific for the H3K9me3 site (Table S1). The struc-
tural studies reported here illustrate that JMJD2A and JMJD2D
employ similar modes of recognition of the H3K9me3 site at
the 1 position through hydrogen bonding to R8 (Figures 2A
and 2B). However, these enzymes display unexpected differ-
ences in the recognition of residues S10 and T11 at the +1
and +2 positions of the H3K9me3 site (Figures 2C and 2D). S10
is pivotal for the recognition of the H3K9me3 site by JMJD2A,
whereas in JMJD2D, this requirement is more flexible owing to
a compensatory interaction formed between T11 and Asp-139
in JMJD2D. In addition, we also demonstrate that phosphoryla-
tion of T11 severely impairs demethylation of H3K9me3 by
JMJD2KDMs (Figure S5A), contrary to previous reports (Metzger
et al., 2008). These findings correlatewith prior studies illustrating
that S10ph abrogates demethylation of H3K9me3 by JMJD2A
(Ng et al., 2007) and are consistent with the overall acidic
character of the S10-T11 binding cleft (Figures 3D and 3E), which
is electrostatically incompatible with the binding of S10ph
and T11ph.
Our structural and biochemical results highlight key interac-
tions at the 1, +1, +2, and +3 positions in the H3K9me38–108, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 103
Figure 3. Differential Recognition of
H3K36me3 by JMJD2 Homologs
(A) Surface representation of JMJD2D (pink) con-
taining the docked H3K36me3 peptide in stick
representation (gray carbons). Purple patches
highlight regions that lack sequence conservation
with JMJD2A.
(B) Steric clashes between H39 and R40 in
H3K36me3 (gray carbons) and Asp-139, Leu-75,
and His-90 in JMJD2D (pink carbons) are shown
as red-dashed lines.
(C) R40 in H3K36me3 (gray carbons) is recognized
by a salt bridge interaction (black-dashed lines)
with Asp-135 in JMJD2A (blue) (PDB entry 2P5B).
Green dashes represent interatomic distances
favorable for substrate binding.
(D and E) Electrostatic surface representations
of JMJD2D (D) and JMJD2A (E). Electrostatic
potential is contoured from +3 kbT 3 e
1 (blue)
to 3 kbT 3 e1 (red). The backbone of the
H3K36me3 peptide (gray) is depicted in cartoon
form with the C-terminal basic residues H39,
R40, and R42 represented in stick form (black).
Yellow arrows denote the positively charged
regions in JMJD2D that would electrostatically
repel the basic C-terminal residues in the
H3K36me3 peptide.
(F) Hydrogen bond between Asp-311 in JMJD2A
(blue) and V35 in H3K36me3 (gray carbons). The
corresponding residue, Arg-316 (pink carbons), in
JMJD2D is unable to form this hydrogen bond due
to structural variability in the GEAR loop motif
(inset).
See also Figures S6 and S8.
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Structural and Functional Analysis of JMJD2Dsequence that are important for substrate recognition by
JMJD2A and JMJD2D. These ‘‘signature’’ residues are also
conserved in other known substrates of JMJD2 KDMs, most
notably K26me3 of the linker histone H1.4 (H1.4K26me3)
(Trojer et al., 2009) (Figure S7). In contrast to H3K9me3 and
H1.4K26me3, JMJD2 homologs display distinct preferences
for H3K36me3, which is efficiently demethylated by JMJD2A,
JMJD2B, and JMJD2C but is not recognized by JMJD2D. Struc-
tural comparisons and docking studies of JMJD2A and JMJD2D
(Figure 3) reveal that steric and electrostatic clashes combined
with a lack of productive interactions contribute to the inability
of JMJD2D to demethylate the H3K36me3 site. Consistent
with these findings, the residues that can favorably accommo-
date H3K36me3 recognition are conserved among JMJD2A,
JMJD2B, and JMJD2C but are divergent in JMJD2D (Figure S8).
Despite their ability to demethylate H3K9me3, JMJD2 KDMs
are inactive toward H3K27me3, a methylation site that mediates
Polycomb group silencing (Cao et al., 2002; Kouzarides, 2007;
Min et al., 2003). Although the H3K9 and H3K27 sequences
harbor a conserved ARKS motif (where K is the methylated104 Structure 21, 98–108, January 8, 2013 ª2013 Elsevier Ltd All rights reservedlysine), sequence variations outside this
ARKS motif, such as P30 in the +3
position, preclude recognition of the
H3K27me3 site by the JMJD2 enzymes
(Chen et al., 2007; Couture et al., 2007;
Ng et al., 2007). A recently reportedcrystal structure of the H3K27me3-specific KDM UTX bound to
an H3K27me3 peptide illustrates key differences in substrate
recognition by UTX and the JMJD2 KDMs (Sengoku and Yo-
koyama, 2011). In JMJD2A and JMJD2D, the H3K9me3 peptide
adopts a W-shaped conformation that is stabilized by interac-
tions from residues R8–G12 (the –1 to +3 positions) in the
H3K9 site. Conversely, UTX binds to an H3K27me3 peptide in
an extended conformation through an extensive network of inter-
actions spanning residues R17–G33, corresponding to the 10
to +6 positions in the H3K27 site. Despite these differences,
UTX and JMJD2 KDMs share certain similarities in their
substrate-binding modes. For example, UTX recognizes R26 in
the1 position of the H3K27me3 site through multiple hydrogen
bonds. Moreover, an R26A mutation abolishes H3K27me3 de-
methylation by UTX, in agreement with the recognition of R8 in
the 1 position of the H3K9me3 site by JMJD2A and JMJD2D
(Figures 2A and 2B; Table 2). Similarly, phosphorylation of
S28 at the +1 position abrogates demethylation of H3K27me3
by UTX, consistent with the mutual exclusivity of S10ph and
K9me3 for demethylation by the JMJD2 enzymes (Ng et al.,
Figure 4. Substrate Specificity of JMJD2D toward Hybrid H3 Peptides
(A) Amino acid sequences of the hybrid peptide substrates derived from the sequences of the H3K9 and H3K36 methylation sites.
(B) Bar graph representing the kcat/Km values of JMJD2D toward H3K36me3 and the hybrid peptide substrates H3K9K36me3, H3K36K9me3, and
H3K36K9me3_V35R. Error bars represent standard error calculated from three replicate assays.
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Structural and Functional Analysis of JMJD2D2007). In summary, the different conformations adopted by the
H3K9me3 and H3K27me3 sequences facilitate distinct recogni-
tion modes by their cognate JmjC KDMs.
Aberrant expression of specific JMJD2 homologs contributes
to the onset or progression of breast, prostate, colon, gastric,
and squamous cell cancers, rendering these enzymes attractive
targets for chemotherapeutic drug design (Cloos et al., 2006; Fo-
dor et al., 2006; Fu et al., 2012; Ishimura et al., 2009; Kauffman
et al., 2011; Kawazu et al., 2011; Kim et al., 2012; Li et al.,
2011a, 2011b; Shi et al., 2011; Shin and Janknecht, 2007; Tan
et al., 2011; Toyokawa et al., 2011; Wissmann et al., 2007;
Yang et al., 2010). In recent years, several studies have reported
synthetic inhibitors of JMJD2 KDMs, many of which possess
moieties that mimic the cosubstrate 2-OG and coordinate the
active-site Fe(II) to achieve high binding affinity (King et al.,
2010; Luo et al., 2011; Rose et al., 2008; Thalhammer et al.,
2011). More recently, a bisubstrate analog fusing 2-OG and
an H3K9 peptide has been developed and crystallized with
JMJD2A, illustrating the potential of bisubstrate peptidomimet-
ics to inhibit JmjC KDMs (Woon et al., 2012). However, these
inhibitors generally lack specificity for different JMJD2 homo-
logs, an essential requirement in targeting cancers linked to
specific JMJD2 enzymes. In JMJD2D, the loop in the C-terminal
region of the catalytic domain possessing the GEAR motif is
juxtaposed to the trimethyllysine binding cleft but is not con-
served in sequence or structure with other JMJD2 homologs
(Figures 3F and S8). It is conceivable that inhibitors can be de-
signed with scaffolds that interact with this loop in different
JMJD2 homologs, thus enhancing inhibitor specificity. In addi-
tion, the kinetic data illustrating that the T11S mutation in the
H3K9me3 peptide augments apparent binding to JMJD2A and
JMJD2D (Table 2; Figure S4) can be exploited in designing pep-
tidomimetic inhibitors that incorporate a hydroxymethyl moiety
that interacts with the T11 binding pocket in the substrate-
binding cleft. In conclusion, the structural and biochemical
data presented here will aid in informing the structure-basedStructure 21, 9design of new demethylase inhibitors that display enhanced
potency and selectivity toward specific JMJD2 KDMs.
EXPERIMENTAL PROCEDURES
Histone H3 Peptides
The 15-mer H3K9me3 peptide that was cocrystallized with JMJD2D was
purchased from New England Peptide and purified with an acetate counter
ion. Methylated histone H3 peptide substrates used in the kinetic analyses
of JMJD2A and JMJD2D were purchased from Anaspec and were purified
with a chloride counter ion. Peptide concentrations were quantified by amino
acid analysis, with the exception of peptides containing a tyrosine, whose
concentrations weremeasured by their absorbance at 274 nm. The sequences
of the peptides used in crystallization and kinetic experiments are listed in
Table S2.
Protein Cloning, Expression, and Purification
For crystallization, the catalytic domain of human JMJD2D (residues 12–342)
was cloned into a variant of pET15b (Millipore EMD Biosciences) with a
tobacco etch virus protease cleavage site for removal of the N-terminal hexa-
histidine tag (Couture et al., 2007). The enzyme was overexpressed in E. coli
BL21 DE3 Rosetta 2 cells (Millipore EMD Biosciences) and purified by Ni
sepharose chromatography (GE Healthcare) followed by removal of the
hexahistidine tag by tobacco etch virus protease and Superdex 200 gel filtra-
tion chromatography (GE Healthcare). The enzyme was concentrated to 10–
20 mg/ml, flash frozen, and stored at –80C. Inductively coupled plasma
high-resolution mass spectrometry analysis of these samples revealed
>40%molar ratio of Ni present in the protein after extensive gel filtration, indi-
cating the presence of Ni(II) in the active site (Krishnan et al., 2012). For deme-
thylase assays, catalytic domains of JMJD2A (residues 1–350), JMJD2B
(residues 9–357), JMJD2C (residues 1–350), and JMJD2D (residues 12–342)
were expressed and purified as Strep(II)-tagged constructs to minimize con-
tamination with inhibitory transition metal ions, as previously reported
(Krishnan et al., 2012), with the exception that JMJD2B was purified in a single
step by StrepTactin affinity chromatography.
Crystallization and Structure Determination
Crystals of JMJD2D,2-OG,H3K9me3 ternary complex were obtained by
vapor diffusion at 4C using 10 mg/ml JMJD2D, 1.5 mM 2-oxoglutarate and
1.5 mM H3K9me3 peptide. Crystals were grown in 7% polyethylene glycol
3350, 0.1 M sodium thiocyanate, and 0.35 M potassium nitrate. Crystals8–108, January 8, 2013 ª2013 Elsevier Ltd All rights reserved 105
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Structural and Functional Analysis of JMJD2Dwere harvested by serial transfer into the crystallization solution supplemented
with 5%, 15%, and 25% 1,3-propanediol and subsequently flash frozen in
liquid nitrogen. To obtain diffraction-quality crystals of the JMJD2D apoen-
zyme, a K93A/K94A mutant was generated based on sequence analysis by
the surface entropy reduction server (Cieslik and Derewenda, 2009; Cooper
et al., 2007; Derewenda and Vekilov, 2006; Goldschmidt et al., 2007). Crystals
of the JMJD2D K93A/K94A mutant were grown at 4C by vapor diffusion using
10 mg/ml protein in 0.2 M calcium acetate, 0.1 M HEPES 7.5, and 10% poly-
ethylene glycol 8000. These crystals were harvested by serial transfer into the
crystallization solution supplemented with 5%, 15%, and 25% glycerol and
then flash frozen in liquid nitrogen. Diffraction data were collected at the LS-
CAT beamline 21-ID-G at the Advanced Photon Source Synchrotron (Argonne,
IL). Data were processed and scaled using HKL2000 (Otwinowski and Minor,
1997). Molecular replacement was performed using MOLREP (Vagin and Te-
plyakov, 1997) with a JMJD2A structure (PDB entry 2Q8C) used as the search
model for the JMJD2D ternary complex. The structure of the complex was
used as a search model for the JMJD2D apoenzyme. Model building and
refinement were conducted using Coot and Refmac, respectively (Emsley
and Cowtan, 2004; Murshudov et al., 1997). TLS refinement was used to
improve the electron density maps of the JMJD2D apoenzyme (Winn et al.,
2001, 2003). Simulated-annealing omit maps were calculated using CNS
(Brunger, 2007; Bru¨nger et al., 1998). After refinement, structures were vali-
dated using MOLPROBITY (Chen et al., 2010). Structural figures were
rendered using PyMOL (Schro¨dinger) and the electrostatic surface was calcu-
lated using the Adaptive Poisson-Boltzmann Solver (APBS) plugin for PyMOL
(Baker et al., 2001).
Demethylase Assays
KDM activity was measured using a formaldehyde dehydrogenase coupled
assay as previously described (Krishnan et al., 2012). The assay was initiated
by the addition of 1.0 mM 2-OG and a variable concentration of peptide
substrate into the assay cocktail containing 50 mM HEPES (pH 7.5), 50 mM
NaCl, 50 mM (NH4)2Fe(SO4)2, 1.0 mM L-ascorbic acid, 1.0 mM NAD
+, 0.1 mM
formaldehyde dehydrogenase (Roy and Bhagwat, 2007), and 1.0 mM JMJD2A
or JMJD2D. NADH fluorescence was monitored (lex 340/lem 490) at 30 s
intervals using a Sapphire 2 microplate reader (Tecan Group). Kinetic data
were processed using GraphPad Prism (GraphPad Software), as previously
described (Krishnan et al., 2012).
ACCESSION NUMBERS
The coordinates and structure factor files for the JMJD2D ternary complex and
apoenzyme structures have been deposited in the Protein Data Bank under
accession codes 4HON and 4HOO, respectively.
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